alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › drug-design

drug-design

2 studies tagged drug-design, dated 2018-12-06 to 2020-01-21. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics 2020-01-21
  2. Interactions between polyoxometalates and biological systems: from drug design to artificial enzymes 2018-12-06

Studies

2 studies carry this tag.

Date range

2018 to 2020

Top journals

  • Current opinion in biotechnology 1
  • International journal of molecular sciences 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. International journal of molecular sciences 2020-01-21 Treatments

    Aging-associated neurodegenerative diseases, which are characterized by progressive neuronal death and synapses loss in human brain, are rapidly growing affecting millions of people globally.

  2. Interactions between polyoxometalates and biological systems: from drug design to artificial enzymes

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Current opinion in biotechnology 2018-12-06 Treatments

    Polyoxometalates have long been studied in a variety of biological applications.

All topic tags with their study counts